IC
SGMO

Ikarian Capital’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Ikarian Capital’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$301K Hold
1,218,671
– – 0.02% 133
2025
Q4 		$512K Sell
1,218,671
-75,981
-6% -$40.3K 0.04% 138
2025
Q3 		$872K Buy
1,294,652
+34,473
+3% +$18.6K 0.09% 121
2025
Q2 		$682K Sell
1,260,179
-600,000
-32% -$356K 0.13% 86
2025
Q1 		$1.22M Hold
1,860,179
– – 0.15% 89
2024
Q4 		$1.9M Buy
+1,860,179
New +$3.4M 0.26% 82

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Ikarian Capital's SGMO Position: Q1 2026 in Review

Ikarian Capital held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2026 at 1,218,671 shares worth $301K. The position accounts for 0.02% of the portfolio, ranked #133.

Ikarian Capital first reported a position in SGMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.9M in Q4 2024. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Ikarian Capital held 1,218,671 shares of SANGAMO THERAPEUTICS INC worth $301K as of Q1 2026.
  • Ikarian Capital left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up 0.02% of Ikarian Capital's portfolio in Q1 2026, its #133 holding.
  • Ikarian Capital first reported a position in SANGAMO THERAPEUTICS INC in Q4 2024 and has held it in 6 quarters since.
  • Ikarian Capital's SANGAMO THERAPEUTICS INC position peaked at $1.9M in Q4 2024.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.